You are viewing a limited version of this profile. To access i3's full capabilities.
DMC Biotechnologies
Save
Company logo (jpg or png)
Parent company

Short description

Developer of bio-based products for multiple product markets, including specialty chemicals, flavors, fragrances, nutraceuticals, and APIs

Founded in 2014
Founded in

Company type Private Public ()
Company type

Industry Group materials & chemicals

Sector fuels & chemicals

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Boulder, CO Boulder, United States
Address
City
State
Zip
Country

Parent Companies

Updated by Cleantech Group on 02/13/2020

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
04/21/2021
Conagen Conagen
DMC Biotechnologies and Conagen have entered into a manufacturing agreement for the commercial production of DMC’s first product, L-alanine. The partnership combines Conagen’s production expertise with DMC's bioprocess technology.
View source    
Confirmed by Conagen
Technology Partner
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
01/28/2022 Continental Grain Company Continental Grain Company , Toyobo Toyobo (2)
Post-money valuation of
Continental Grain Company, through their venture arm Conti Ventures, and Toyobo have joined the Series B fundraising round, bringing the total raised to $39 million.
Series B $5,000,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font